Skip to main content
Fig. 1 | Annals of Clinical Microbiology and Antimicrobials

Fig. 1

From: Comparison of the inoculum effect of in vitro antibacterial activity of Imipenem/relebactam and Ceftazidime/avibactam against ESBL-, KPC- and AmpC-producing Escherichia coli and Klebsiella pneumoniae

Fig. 1

Time-kill curves for different inocula of ATCC-BAA 1705 (A–C), E. coli 56706 (D–F), K. pneumoniae 61089 (G–I) and K. pneumoniae 60700 (J–L) exposed to CZA and IMR. Data are expressed as the mean ± SD. The left-hand panels depict an inoculum of 105 CFU/mL; the middle panels show an inoculum of 107 CFU/mL; the right-hand panels show an inoculum of 109 CFU/mL. CZA, ceftazidime/avibactam; IMR, imipenem/relebactam

Back to article page